pyrazolanthrone has been researched along with Bone Loss, Osteoclastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbas, S; Abu-Amer, Y; Dai, S; Hirayama, T; Yamanaka, Y | 1 |
Abu-Amer, Y; Clohisy, JC; Faccio, R; Yamanaka, Y | 1 |
2 other study(ies) available for pyrazolanthrone and Bone Loss, Osteoclastic
Article | Year |
---|---|
Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation.
Topics: Animals; Anthracenes; Arthritis, Experimental; Bone Marrow Cells; Bone Resorption; Carrier Proteins; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; JNK Mitogen-Activated Protein Kinases; Leg Bones; Macrophages; MAP Kinase Kinase 4; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Knockout; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Osteoclasts; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction; STAT6 Transcription Factor; Trans-Activators | 2005 |
Map kinase c-JUN N-terminal kinase mediates PMMA induction of osteoclasts.
Topics: Animals; Anthracenes; Arthroplasty, Replacement; Bone Resorption; DNA; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Male; Mesenchymal Stem Cells; Mice; Mice, Knockout; Osteoclasts; Phosphorylation; Polymethyl Methacrylate; Toll-Like Receptor 4; Transcription Factor AP-1 | 2006 |